Abstract
Purpose Pathogenic variants in Kinesin Family Member 1A (KIF1A) are associated with KIF1A-associated neurological disorder (KAND). We report the clinical phenotypes and correlate genotypes of individuals with KAND.
Methods Medical history and adaptive function were assessed longitudinally. In-person evaluations included neurological, motor, ophthalmologic and cognitive assessments.
Results We collected online data on 177 individuals. Fifty-seven individuals were also assessed in-person. Most individuals had de novo heterozygous missense likely pathogenic/pathogenic KIF1A variants. The most common characteristics were hypotonia, spasticity, ataxia, seizures, optic nerve atrophy, cerebellar atrophy, and cognitive impairment. Mean Vineland Adaptive Behavior Composite score (VABS-ABC) was low (M=62.9, SD=19.1). The mean change in VABS-ABC over time was -3.1 (SD=7.3). The decline in VABS-ABC was associated with the age at first assessment and abnormal electroencephalogram/seizure. There was a positive correlation between Evolutionary Scale Model (ESM) score for the variants and final VABS-ABC (p=0.003). Abnormal electroencephalogram/seizure, neuroimaging result, and ESM explain 34% of the variance in final VABS-ABC (p<0.001).
Conclusion In-person assessment confirmed caregiver report and identified additional visual deficits. Adaptive function declined over time consistent with both the neurodevelopmental and neurodegenerative nature of the condition. Using ESM score assists in predicting phenotype across a wide range of unique variants.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by grant R01NS114636 and R35GM149527
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee/IRB of Columbia University gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Email: khemika.sudnawa{at}childrens.harvard.edu
Email: wl2907{at}cumc.columbia.edu
Email: sc5009{at}cumc.columbia.edu
Email: chy2112{at}cumc.columbia.edu
Email: jb3634{at}cumc.columbia.edu
Email: aha2133{at}cumc.columbia.edu
Email: Alexa.Geltzeiler{at}childrens.harvard.edu
Email: carolinemebane{at}gmail.com
Email: fap2005{at}cumc.columbia.edu
Email: tts27{at}cumc.columbia.edu
Email: rf237{at}cumc.columbia.edu
Email: jm598{at}cumc.columbia.edu
Email: ys2411{at}cumc.columbia.edu
Declarations
Ethics approval and consent to participate
The study was approved by the Columbia University Institutional Review Board (AAAJ8651 and AAAT8830), and informed consent was obtained from all participants or their guardians.
Consent for publication
Not applicable
Availability of data and materials
The datasets used and/or analyzed during the current study are available from the corresponding author on request.
Conflict of Interest
The authors declare no conflict of interest.
Funding
The work was funded by grant R01NS114636 and R35GM149527
Authors Information
Conceptualization: WKC, JM, RJF, JMB, AHA; Data curation: KKS, SC, CHK, JMB, AHA, FP, TTS; Formal Analysis: KKS, WL, CHK, JMB, AHA, FP, TTS; Funding Acquisition: WKC; Methodology: KKS, WL, SC, CHK, JMB, AHA, FP, TTS, RJF, JM, YS, WKC; Investigation: KKS, SC, CHK, JMB, AHA, AG, CMM, FP, TTS, RJF, JM; Project Administration: SC; Writing-original draft: KKS, WL, CHK, JMB, AHA, FP, TTS; Writing-review and editing: KKS, WL, CHK, JMB, AHA, FP, TTS, RJF, JM, YS, WKC; Supervision: WKC
Data Availability
All data produced in the present study are available upon reasonable request to the authors